- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02825641
Premature Rupture of Membranes With a Bishop Score<6: Comparison of Medical Induction/Expectant Management
Premature Rupture of Membranes at Term With an Unfavorable Cervix (Bishop Score<6): Comparison of Oxytocin, Dinoprostone Induction and Expectant Management
The study is intended to compare expectant management and on presentation labor induction in women with premature rupture of membranes.
The means of labor induction and cervical ripening are either oxytocin or dinoprostone.
Expectant management in this obstetrical state means waiting 24 hours from the onset of rupture of membranes and then commencing labor induction with either oxytocin or dinoprostone depending on the patient's obstetrical history and cervical condition.
The investigators' hypothesis is that active management will lead to a higher rate of vaginal deliveries, a shorter interval between the time of rupture of membranes and the time of delivery, a lower rate of cesarean sections and a better obstetric result for the mother and the fetus/newborn.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the setting of premature rupture of membranes in term pregnancies, it is customary in women who are not in active labor to wait for 24 hours before attempting to induce labor. The means of labor induction used at our medical center are either intravenous oxytocin or per-vaginal dinoprostone, depending on patient's obstetric history and cervical conditions.
The investigators hypothesize that commencing induction of labor at presentation in these women by either means of induction will lead to higher rates of vaginal delivery, shorter intervals between the time of onset of rupture of membranes and the time of delivery and lower rates of cesarean sections.
The participants in the study, upon signing informed consents, will be randomized to 4 groups-2 groups of expectant management in which labor induction will be commenced after 24 hours with either oxytocin or dinoprostone and 2 groups of active management in which labor induction will be commenced at presentation with either oxytocin or dinoprostone.
The participants will be followed from the time of presentation with rupture of membranes at the delivery room and until the time of delivery.
Further obstetric, clinical and demographic information will be acquired from the patient's electronic medical file for analysis accuracy and sub-analysis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel
- Rambam Health Care Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Term pregnancies >37 weeks of gestation.
- Certain rupture of membranes.
- Bishop score < 6.
- Singleton pregnancies.
- Vertex presentation.
- No obstetric or clinical contraindications for labor induction.
- Reactive non stress test on presentation.
Exclusion Criteria:
- Previous cesarean section.
- Previous uterine surgeries (Myomectomy etc.).
- Placenta Previa.
- Multiple gestation pregnancies.
- Pregnancies with history of fetal reduction or Intrapartum uterine fetal demise.
- Known fetal defects/Chromosomal abnormalities.
- Active genital Herpes.
- HIV carrier.
- Contractions that are less than 10 minutes apart.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Expectant Management-Dinoprostone
Women with premature rupture of membranes who are not in active labor and have an unfavorable cervix (Bishop score<6). Labor induction will be initiated with Dinoprostone after 24 hours of waiting depending on obstetric history and cervical conditions. |
Labor induction and cervical ripening by dinoprostone in women with premature rupture of membranes in 2 types of women:
Other Names:
|
Active Comparator: Expectant Management-Oxytocin
Women with premature rupture of membranes who are not in active labor and have an unfavorable cervix (Bishop score<6). Labor induction will be initiated with oxytocin after 24 hours of waiting depending on obstetric history and cervical conditions. |
Labor induction and cervical ripening by oxytocin in women with premature rupture of membranes in 2 types of women:
Other Names:
|
Experimental: Active Management-Dinoprostone
Women with premature rupture of membranes who are not in active labor and have an unfavorable cervix (Bishop score<6). Labor induction will be initiated with Dinoprostone on presentation depending on obstetric history and cervical conditions. |
Labor induction and cervical ripening by dinoprostone in women with premature rupture of membranes in 2 types of women:
Other Names:
|
Experimental: Active Management-Oxytocin
Women with premature rupture of membranes who are not in active labor and have an unfavorable cervix (Bishop score<6). Labor induction will be initiated with oxytocin on presentation depending on obstetric history and cervical conditions. |
Labor induction and cervical ripening by oxytocin in women with premature rupture of membranes in 2 types of women:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vaginal delivery rate
Time Frame: Up to 7 days from the time of presentation with rupture of membranes
|
The percentage of participants that achieved vaginal delivery
|
Up to 7 days from the time of presentation with rupture of membranes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Interval to delivery
Time Frame: Up to 7 days from the time of presentation with rupture of membranes
|
Interval from the time of onset of premature rupture of membranes and the time of delivery (In minutes)
|
Up to 7 days from the time of presentation with rupture of membranes
|
Caesarian delivery rate
Time Frame: Up to 7 days from the time of presentation with rupture of membranes
|
The percentage of participants that required caesarian delivery
|
Up to 7 days from the time of presentation with rupture of membranes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amir Weissman, MD, Rambam Health Care Campus
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0213-15-RMB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medical Induction of Labor Affecting Newborn
-
Ain Shams UniversityUnknownMedical Induction of Labor Affecting FetusEgypt
-
Kasr El Aini HospitalUnknownMedical Induction of Labor Affecting FetusEgypt
-
Kaplan Medical CenterUnknownFailed Medical or Unspecified Induction of Labor
-
Holy Family Hospital, Nazareth, IsraelNot yet recruitingInduction of Labor Affected Fetus / NewbornIsrael
-
Meir Medical CenterActive, not recruitingInduction of Labor Affected Fetus / NewbornIsrael
-
Wake Forest University Health SciencesCompletedInduction of Labor Affected Fetus / NewbornUnited States
-
Rambam Health Care CampusCompletedInduction of Labor Affected Fetus / NewbornIsrael
-
Intermountain Health Care, Inc.Ferring PharmaceuticalsTerminatedInduction of Labor Affected Fetus / NewbornUnited States
-
Ascension Genesys HospitalCompletedInduction of Labor Affected Fetus / NewbornUnited States
-
Ain Shams Maternity HospitalUnknownInduction of Labor Affected Fetus / NewbornEgypt
Clinical Trials on Dinoprostone
-
Cairo UniversityCompletedDinoprostone TimingEgypt
-
Seoul National University HospitalCompletedNulliparous Women Who Scheduled for Labor InductionKorea, Republic of
-
Università degli Studi di BresciaCompletedLabor, Induced | Cervical RipeningItaly
-
Intermountain Health Care, Inc.Ferring PharmaceuticalsTerminatedInduction of Labor Affected Fetus / NewbornUnited States
-
Hospital Universitario 12 de OctubreInstituto de Salud Carlos III; Spanish Clinical Research Network - SCReNRecruitingFetal Growth RetardationSpain
-
Mednax Center for Research, Education, Quality...Completed
-
Weill Medical College of Cornell UniversityCompletedCervical Ripening | Labor InductionUnited States
-
Zeynep Kamil Maternity and Pediatric Research and...CompletedEarly Amniotomy, Unfavorable CervixTurkey
-
Cairo UniversityCompletedIntrauterine DeviceEgypt
-
Clinical Hospital MerkurCompletedInduction of Labor Affected Fetus / Newborn | Prostaglandins Causing Adverse Effects in Therapeutic UseCroatia